Trials / Completed
CompletedNCT02771470
Intestinal Microflora in Lung Cancer After Chemotherapy
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Probiotics modulate the gut microflora and immune status in lung cancer who need chemotherapy.
Detailed description
Chemotherapy destroys the intestinal mucosal barrier, affects intestinal flora, causing bacterial translocation, infection and other complications. Probiotics may restore the intestinal immunity, mucosal barrier and nutrient absorption.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Probiotics | Microbial composition using probiotic |
| DRUG | placebo | Microbiota modulation using placebo |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2016-05-13
- Last updated
- 2017-05-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02771470. Inclusion in this directory is not an endorsement.